Integra LifeSciences Holdings Corp (IART) - Financial and Strategic SWOT Analysis Review

Region:North America

Author(s):

Product Code:GDME717FSA

Download Sample Report download
Buy the Full ReportStarting from $125
Published on

April 2019

Total pages

65

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $125

About the Report

About the Report

Integra LifeSciences Holdings Corp (IART)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Integra LifeSciences Holdings Corp (Integra) is a medical technology company, which offers engineered collagen-based product lines. The company's portfolio consists of surgical instruments, advanced wound care and orthopedic hardware, specialty metal implants, dermal regeneration products, orthobiologic products, tissue-engineered wound dressings, and nerve and tendon repair products. Its neurosurgery products include ultrasonic surgery systems, systems for measurement of various brain parameters, cranial stabilization and brain retraction systems, and others. Integra's products find application in orthopedic extremity surgery, neurosurgery, and reconstructive and general surgery. Integra serves hospitals, outpatient surgery centers, physician, veterinarian and dental practices. The company markets its solutions through direct sales representatives and an extensive network of distributors. Integra is headquartered in Plainsboro, New Jersey, the US.

Integra LifeSciences Holdings Corp Key Recent Developments

Mar 14,2019 Integra LifeSciences Announces the Approval of DuraGen in Japan | Integra LifeSciences Holdings Corporation

Feb 21,2019 Integra LifeSciences reports fourth quarter and full-year 2018 financial results and provides 2019 financial guidance

Jan 09,2019 Integra LifeSciences appoints Rhonda Germany Ballintyn as Director

Jan 09,2019 Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director | Integra LifeSciences Holdings Corporation

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Products


Companies

Zimmer Biomet Holdings Inc

Wright Medical Group NV

Stryker Corp

Smith & Nephew Plc

MiMedx Group Inc

Medtronic Plc

LifeCell Corp

Johnson & Johnson

DePuy Synthes Inc

Becton Dickinson and Co

Table of Contents

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Integra LifeSciences Holdings Corp-Key Facts

Integra LifeSciences Holdings Corp-Key Employees

Integra LifeSciences Holdings Corp-Key Employee Biographies

Integra LifeSciences Holdings Corp-Major Products and Services

Integra LifeSciences Holdings Corp-History

Integra LifeSciences Holdings Corp-Company Statement

Integra LifeSciences Holdings Corp-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Integra LifeSciences Holdings Corp-Business Description

Business Segment: Codman Specialty Surgical

Overview

Performance

Business Segment: Orthopedics and Tissue Technologies

Overview

Performance

Geographical Segment: Asia Pacific

Performance

Geographical Segment: Europe

Performance

Geographical Segment: Rest of World

Performance

Geographical Segment: The US

Performance

R&D Overview

Integra LifeSciences Holdings Corp-Corporate Strategy

Integra LifeSciences Holdings Corp-SWOT Analysis

SWOT Analysis-Overview

Integra LifeSciences Holdings Corp-Strengths

Integra LifeSciences Holdings Corp-Weaknesses

Integra LifeSciences Holdings Corp-Opportunities

Integra LifeSciences Holdings Corp-Threats

Integra LifeSciences Holdings Corp-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Integra LifeSciences Holdings Corp, Recent Deals Summary

Section 5-Company's Recent Developments

Mar 14, 2019: Integra LifeSciences Announces the Approval of DuraGen in Japan | Integra LifeSciences Holdings Corporation

Feb 21, 2019: Integra LifeSciences reports fourth quarter and full-year 2018 financial results and provides 2019 financial guidance

Jan 09, 2019: Integra LifeSciences appoints Rhonda Germany Ballintyn as Director

Jan 09, 2019: Integra LifeSciences Appoints Rhonda Germany Ballintyn as Director | Integra LifeSciences Holdings Corporation

Jan 08, 2019: Integra LifeSciences announces preliminary fourth quarter 2018 financial results

Nov 20, 2018: Integra XT Revision Total Ankle Replacement System Offers Innovative Solution to Ankle Arthroplasty Revision Surgery

Oct 31, 2018: Integra LifeSciences reports third quarter 2018 financial results

Sep 05, 2018: 2018 Veeva R&D summit to showcase advances for speeding product development

Jul 25, 2018: Integra LifeSciences Reports Second Quarter 2018 Financial Results

May 07, 2018: Integra LifeSciences Announces Amendment and Extension of Credit Facility

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List of Figure

List of Figures

Integra LifeSciences Holdings Corp, Performance Chart (2014-2018)

Integra LifeSciences Holdings Corp, Ratio Charts

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Integra LifeSciences Holdings Corp, Medical Equipment, Deals by Type, 2013 to YTD 2019


List of Table

List of Tables

Integra LifeSciences Holdings Corp, Key Facts

Integra LifeSciences Holdings Corp, Key Employees

Integra LifeSciences Holdings Corp, Key Employee Biographies

Integra LifeSciences Holdings Corp, Major Products and Services

Integra LifeSciences Holdings Corp, History

Integra LifeSciences Holdings Corp, Other Locations

Integra LifeSciences Holdings Corp, Subsidiaries

Integra LifeSciences Holdings Corp, Key Competitors

Integra LifeSciences Holdings Corp, Ratios based on current share price

Integra LifeSciences Holdings Corp, Annual Ratios

Integra LifeSciences Holdings Corp, Annual Ratios (Cont...1)

Integra LifeSciences Holdings Corp, Annual Ratios (Cont...2)

Integra LifeSciences Holdings Corp, Interim Ratios

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Year, 2013 to YTD 2019

Integra LifeSciences Holdings Corp, Medical Equipment, Deals By Type, 2013 to YTD 2019

Integra LifeSciences Holdings Corp, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022